Hematopoietic reprogramming can lead to differentiated blood products for cell-replacement therapy
Building upon previous work, researchers at the Icahn School of Medicine at Mount Sinai identified cells in the embryos of mice that are precursors to blood stem cells or hematopoietic stem/progenitor cells.